Task: Answer the multiple choice question.
Question: Which drug exhibits a 2.571% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a. Cc1nc2ccccn2c(=O)c1NC(=O)c1cccs1
b. O=C(Nc1nnc(-c2ccc(F)cc2)s1)c1c(F)cccc1Cl
c. Cc1nn(Cc2ccc(Cl)cc2Cl)c(Cl)c1C(=O)O
Answer: c. Cc1nn(Cc2ccc(Cl)cc2Cl)c(Cl)c1C(=O)O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nn(Cc2ccc(Cl)cc2Cl)c(Cl)c1C(=O)O
Cc1nn(Cc2ccc(Cl)cc2Cl)c(Cl)c1C(=O)O
5-chloro-1-[(2,4-dichlorophenyl)methyl]-3-methylpyrazole-4-carboxylic acid